Semaglutide reduces the absolute risk of major cardiovascular events by 1.5. Phizackerley D. BMJ 2024;384:q53.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Phizackerley D. Semaglutide reduces the absolute risk of major cardiovascular events by 1.5. BMJ 2024;384:q53.
PMID: 38224977